Phase II evaluation of docetaxel randomized with doxercalciferol or placebo in patients with advanced prostate cancer
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Docetaxel (Primary) ; Doxercalciferol (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 21 Jan 2008 New trial record.